We were the first to report that mutations of ASXL1 occur in chronic myeloid leukemia (CML) [17], and ASXL1 mutations have been associated with disease progression and blast crisis in CML [18, 19]. The gene discussed is ASXL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.